Jamie Jones

Jamie has 17 years’ experience as a programmer and a data manager in the pharmaceutical industry.

Jamie has a broad experience of working within a CRO – both at a small Phase I unit as well as Global CROs – progressing through the ranks to manager level. His varied career has given him exposure working on various phases and therapeutic areas.

With a proven track record in line management, Jamie is well placed to support Veramed’s expansion and lead the South Wales office in Swansea.

Diana Stuart

Diana has been programming in SAS since 1996, moving from banking to the pharmaceutical industry in 1998. Her experience includes ten years as an independent contractor and involved working for a number of pharmaceutical companies with a significant global presence.

Diana’s roles have allowed exposure to multiple therapeutic areas and clinical trial phases from Phase I through to Phase IV. She has significant experience in Early Development and Phase I to III Oncology, as well as the production and management of iDMC packages.

Since 2009 Diana has been an active member of Pharmaceutical Users Software Exchange (PhUSE), presenting at their annual conference almost every year with an emphasis on professional development. She has held the role of PhUSE Newsletter Editor for over eight years.

Andrew Holmes

Andrew has over twenty years’ biostatistical experience in academia and industry from varied roles ranging from basic research through veterinary and pre-clinical work to late phase development applications.

His expertise includes clinical biostatistics; clinical study design, reporting and logistics; imaging informatics and medical image analysis, with applications in multiple therapeutic areas including neuroscience, cardiovascular, oncology and respiratory.

He also has detailed understanding of computing infrastructures, having been involved in software development, training and support.

Formally trained in pure mathematics (BSc, University of Durham, 1990) and statistics (MSc, University of Sheffield, 1991), Andrew gained a PhD from the University of Glasgow in 1994 for research into statistical methods for functional neuroimaging. He has co-authored numerous publications, book chapters and software packages.

Vicki Slater

Vicki has over twenty years of experience within the pharmaceutical industry, initially beginning her career as a bio analyst, within the field of toxicology, then moving into statistical programming in 1998.

She has held various positions of ascending seniority and has lead Global Programming Teams across multiple therapeutic areas and clinical trial phases from Phase I through to Phase IV.

She has significant experience in Late Development Oncology, Cardiovascular and Infectious disease therapy areas.

She has extensive experience in project management, and has overseen and driven the delivery of programming activities across multiple programs simultaneously, including submission deliverables, regulatory defence and reimbursement activities.

Vicki has a BSc in Biochemistry from Lancaster University (1995).

Clare Newall

Clare has over 10 years experience in the pharmaceutical industry as well as a further 10 years working in the field of respiratory medicine, the latter in which she holds a PhD. Her experience spans a range of therapeutic areas (including respiratory, cardiovascular, CNS and autoimmune disease) and study phases, and includes significant early development expertise as well as pharmacokinetic studies. She also has outstanding leadership, project and process management skills, having held previous managerial positions in a global clinical research organization.

Clare has an MSc in Medical Statistics (2005, University of Leicester) with a first degree in Natural Sciences (1995, University of Cambridge).